Grand Challenges: Blueprint Empowers Drug Development for Nervous System Disorders 

You are viewing archived Blueprint content that is no longer current but is available for reference and record keeping purposes.

Thursday, August 18, 2011

The Blueprint Neurotherapeutics Network helps investigators develop new drugs for nervous system disorders and prepare for clinical trials. The Network recently made awards to seven teams across the U.S. to develop new therapies for vision loss, neurodegenerative diseases, and depression, among others.

View the full article.